Cite
The transmembrane protease serine (TMPRSS3/TADG-12) D variant: a potential candidate for diagnosis and therapeutic intervention in ovarian cancer.
MLA
Sawasaki, Takashi, et al. “The Transmembrane Protease Serine (TMPRSS3/TADG-12) D Variant: A Potential Candidate for Diagnosis and Therapeutic Intervention in Ovarian Cancer.” Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 25, no. 3, May 2004, pp. 141–48. EBSCOhost, https://doi.org/10.1159/000079146.
APA
Sawasaki, T., Shigemasa, K., Gu, L., Beard, J. B., & O’Brien, T. J. (2004). The transmembrane protease serine (TMPRSS3/TADG-12) D variant: a potential candidate for diagnosis and therapeutic intervention in ovarian cancer. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine, 25(3), 141–148. https://doi.org/10.1159/000079146
Chicago
Sawasaki, Takashi, Kazushi Shigemasa, Lijun Gu, John B Beard, and Timothy J O’Brien. 2004. “The Transmembrane Protease Serine (TMPRSS3/TADG-12) D Variant: A Potential Candidate for Diagnosis and Therapeutic Intervention in Ovarian Cancer.” Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 25 (3): 141–48. doi:10.1159/000079146.